Granules’ generic anticholinergic drug gets U.S. FDA nod
The Hindu
Granules India's Glycopyrrolate Oral Solution approved by U.S. FDA for paediatric patients with neurological conditions.
Drugmaker Granules has received U.S. Food and Drug Administration (U.S. FDA) approval for its abbreviated new drug application (ANDA) for Glycopyrrolate Oral Solution 1mg/5mL.
The approved product will be bioequivalent and therapeutically equivalent to the reference listed drug Merz Pharmaceuticals LLC’s Cuvposa Oral Solution1 mg/5 mL, Granules India said in a release on the U.S. FDA nod for subsidiary Granules Pharmaceuticals Inc. (GPI) ANDA.
Glycopyrrolate Oral Solution is an anticholinergic medication indicated for paediatric patients aged 3-16 years who have neurological conditions associated with problem drooling. “As we strengthen Granules’ footprint in the U.S. market, this approval highlights our robust quality systems, ensuring compliance with the highest regulatory standards,” said Granules India CMD Krishna Prasad Chigurupati said.
Granules India shares closed 1.77% higher at ₹.673.95 each on the BSE.
RBI to launch a two-month campaign in January 2026 to address pending grievances with the Ombudsman for improved customer service.
RBI plans ₹1 lakh crore OMO in December to boost liquidity amid upcoming tax payments, ensuring stability in the banking system.
IndiGo faces ongoing flight delays and cancellations due to technology issues, weather, and new crew rostering rules.
Stock markets experience volatility as investors await RBI's monetary policy amid foreign fund outflows and mixed global trends.
ED attaches assets worth ₹1,120 crore in Anil Ambani's Reliance Group case, totaling ₹10,000 crore amid money laundering probe.
Rupee rises 20 paise to 89.69 against the dollar as investors await RBI's monetary policy decision amidst market pressures.
Just nine Fugitive Economic Offenders (FEOs) owed Indian banks over ₹58,000 crore in principal and interest. To date, banks have recovered just over ₹19,000 crore — roughly 33% of the total dues.
Commerce Minister Piyush Goyal urges Indian businesses to seize opportunities in Russia's market, addressing talent shortages and trade demands.
Premiumisation is driving the growth in beauty and personal care industry in India and this segment is growing faster than the products made for the masses, industry executives said at Cosmoprof India 2025, a beauty & personal care industry event currently underway in Mumbai.
Scaling Artificial Intelligence(AI) at the speed at which consultants project is not possible by the laws of physics and may not be environmentally sustainable, said Tanvir Khan, who is the Executive Vice President and Chief Operating Officer of NTT DATA North America, part of the Japanese technology services and data centre company NTT Data, in an interview with The Hindu.
The Rupee appreciated by 19 paise to close at 89.96 against the U.S. dollar amid weak dollar index support.
India aims to expand its tea exports to China, highlighting diverse varieties like Darjeeling and Masala at a recent buyer-seller meet.
Stock markets rebound after four days of decline as Sensex rises 158 points, driven by tech and IT shares.